FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084713 [Registered on: 15/04/2025] Trial Registered Prospectively
Last Modified On: 18/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Other 
Public Title of Study   Comparing Two Medicines to Help Children Relax Before Surgery: Dexmedetomidine vs Midazolam  
Scientific Title of Study   A Study Comparing Nebulised Dexmedetomidine vs midazolam as premedicant in pediatric patient undergoing elective surgery 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Yashika Yadav 
Designation  Post Graduate Student 
Affiliation  Jawaharlal Nehru Medical College and hospital  
Address  Department of anaesthesia, Jawaharlal Nehru Medical College and hospital ajmer, rajasthan 305001 India

Ajmer
RAJASTHAN
305001
India 
Phone  9468177278  
Fax    
Email  ydvyashika99@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pooja Mathur 
Designation  Professor 
Affiliation  Jawaharlal Nehru Medical College and hospital ajmer rajasthan ,305001 
Address  Department of anaesthesia, Jawaharlal Nehru Medical College and hospital, ajmer, rajasthan

Ajmer
RAJASTHAN
305001
India 
Phone  9414003933  
Fax    
Email  drpoojarawat@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pooja Mathur 
Designation  Professor 
Affiliation  Jawaharlal Nehru Medical College and hospital ajmer rajasthan ,305001 
Address  Department of anaesthesia, Jawaharlal Nehru Medical College and hospital, ajmer, rajasthan

Ajmer
RAJASTHAN
305001
India 
Phone  9414003933  
Fax    
Email  drpoojarawat@gmail.com  
 
Source of Monetary or Material Support  
Jawaharlal Nehru Medical College and hospital ajmer rajasthan,305001 
 
Primary Sponsor  
Name  Jawaharlal Nehru Medical College and hospital  
Address  Jawaharlal Nehru Medical College and hospital ajmer rajasthan,India , 305001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Yashika Yadav  JLN Medical College, Ajmer, Rajasthan  Department of Anesthesia, new ot, first floor, JLN Hospital, Kalakand Bagh, Ajmer, Rajasthan
Ajmer
RAJASTHAN 
9468177278

ydvyashika99@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Principal and controller JLNMC AJMER  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NEBULISED inj DEXMEDETOMIDINE 2MICROGRAM /KG nebulised inj midazolam 2mg/kg  with due approval from the institutional ethical comittee, a prospective randomised double blind study is planned on 90 patients aged 3-10 years who will be undergoing elective surgical procedures under general anesthesia, participants will be allocated in group D receiving nebulised dexmedetomidine and group M receiving nebulised midazolam at above mentioned doses will be compared for sedation ,parent separation anxiety, face mask acceptance, emergence reaction , a written and informed consent will be taken from parents of participants. 
Intervention  NEBULISED inj DEXMEDETOMIDINE 2MICROGRAM /KG nebulised inj midazolam 2mg/kg  with due approval from the institutional ethical comittee, a prospective randomised double blind study is planned on patients aged 3-10 years who will undergoing elective surgical procedures under general anesthesia, participants will be allocated in group d receiving nebulised dexmedetomidine and group M receiving nebulised midazolam at above mentioned doses will be compared for sedation ,parent separation anxiety, face mask acceptance, emergence reaction , a written and informed consent will be taken from parents of participants. 
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  10.00 Year(s)
Gender  Both 
Details  1 patients belonging to ASA physical status 1 and 2
2 patients aged 3-10years
3 patients posted for elective surgical procedures under general anesthesia 
 
ExclusionCriteria 
Details  1 parent refusal
2 emergency
3 children with known allergy to study drugs
4 significant organ dysfunction
5 congenital disorders
6 behavioural disorders
7 children with more than 85th percentile of body mass index for age percentiles 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
assessment of sedation score  Baseline 
 
Secondary Outcome  
Outcome  TimePoints 
parental separation score  at 5min, 10min, 20min, 30min 
mask acceptance score  at 5min, 10min, 20min, 30min 
assessment of recovery   
assessment of emergence agitation   
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This will be a double blinded randomised study conducted to evaluate efficacy of nebulised dexmedetomidine 2micogram/kg and nebulised midazolam0.2mg/kg, study drugs will be diluted in 3ml of 0.9% normal saline  as premedication in children aged between 3-10 years undergoing surgery under general anesthesia ,administred 30 mins before the induction of general anesthesia via jet nebuliser , in ASA 1 or 2 patients with exemption of all exclusion criteria mentioned above with primary objective of comparing the efficacy of nebulised dexmedetomidine and nebulised midazolam as sedative premedication . Secondary objectives being comparing the premedicants in terms of achieving ,alleviating parent separation anxiety, providing better face mask acceptance, least emergence reactions. Group D receiving nebulised dexmedetomidine and group M receving nebulised midazolam in above mentioned doses. preanesthetic  evaluation will be done previous day, informed written consent will be taken prior to surgery , all emergency drugs and equipments will be kept ready in prior. patient will be monitored preoperative, intraoperative and postoperatively. the parameters will be recorded at predescribed intervals and documented . data will be analysed statistically using  standard qualitative and quantitative tests , continous variables will be analysed using student paired test and categorical variables will be analysed using chi square test . P value less than 0.05 will be considred significant.

 
Close